ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Vaginal Fungal Infections Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27A13667
Home | Market Reports | Health| Reproductive Health
Global Drugs for Vaginal Fungal Infections Market Research Report 2023
BUY CHAPTERS

Global Drugs for Vaginal Fungal Infections Market Research Report 2025

Code: QYRE-Auto-27A13667
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Bausch Health Companies Inc.
Hikma Pharmaceuticals PLC
Lupin Ltd
Mycovia Pharmaceuticals, Inc
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy’s Laboratories
Scynexis Inc
Basilea Pharmaceutica Ltd
Grupo Ferrer Internacional, S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc
Cidara Therapeutics, Inc
Amplyx Pharmaceuticals Inc
ANl Pharmaceuticals, Inc
Astellas Pharma lnc.

Drugs for Vaginal Fungal Infections Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drugs for Vaginal Fungal Infections Market

Drugs for Vaginal Fungal Infections Market

The global market for Drugs for Vaginal Fungal Infections was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Vaginal Fungal Infections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Vaginal Fungal Infections.
The Drugs for Vaginal Fungal Infections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Vaginal Fungal Infections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Vaginal Fungal Infections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drugs for Vaginal Fungal Infections Market Report

Report Metric Details
Report Name Drugs for Vaginal Fungal Infections Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Bausch Health Companies Inc, ANl Pharmaceuticals, Inc, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS,Inc., Basilea Pharmaceutica Ltd., Astellas Pharma lnc., Grupo Ferrer Internacional,S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drugs for Vaginal Fungal Infections company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs for Vaginal Fungal Infections Market report?

Ans: The main players in the Drugs for Vaginal Fungal Infections Market are Pfizer Inc., Bausch Health Companies Inc, ANl Pharmaceuticals, Inc, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS,Inc., Basilea Pharmaceutica Ltd., Astellas Pharma lnc., Grupo Ferrer Internacional,S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc.

What are the Application segmentation covered in the Drugs for Vaginal Fungal Infections Market report?

Ans: The Applications covered in the Drugs for Vaginal Fungal Infections Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Drugs for Vaginal Fungal Infections Market report?

Ans: The Types covered in the Drugs for Vaginal Fungal Infections Market report are Fluconazole, Nystatin, Flucytosine, Clotrimazole, Others

Recommended Reports

Gynecological Drugs

Fungal Infection Therapies

Infectious Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluconazole
1.2.3 Nystatin
1.2.4 Flucytosine
1.2.5 Clotrimazole
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drugs for Vaginal Fungal Infections Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Vaginal Fungal Infections Market Perspective (2020-2031)
2.2 Global Drugs for Vaginal Fungal Infections Growth Trends by Region
2.2.1 Global Drugs for Vaginal Fungal Infections Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Vaginal Fungal Infections Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Vaginal Fungal Infections Market Dynamics
2.3.1 Drugs for Vaginal Fungal Infections Industry Trends
2.3.2 Drugs for Vaginal Fungal Infections Market Drivers
2.3.3 Drugs for Vaginal Fungal Infections Market Challenges
2.3.4 Drugs for Vaginal Fungal Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue
3.1.1 Global Top Drugs for Vaginal Fungal Infections Players by Revenue (2020-2025)
3.1.2 Global Drugs for Vaginal Fungal Infections Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Vaginal Fungal Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Vaginal Fungal Infections Revenue
3.4 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio
3.4.1 Global Drugs for Vaginal Fungal Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Vaginal Fungal Infections Revenue in 2024
3.5 Global Key Players of Drugs for Vaginal Fungal Infections Head office and Area Served
3.6 Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
3.7 Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Vaginal Fungal Infections Breakdown Data by Type
4.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031)
5 Drugs for Vaginal Fungal Infections Breakdown Data by Application
5.1 Global Drugs for Vaginal Fungal Infections Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
6.2 North America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
6.4 North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Vaginal Fungal Infections Market Size (2020-2031)
7.2 Europe Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
7.4 Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Vaginal Fungal Infections Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Vaginal Fungal Infections Market Size (2020-2031)
9.2 Latin America Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
9.4 Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Vaginal Fungal Infections Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Drugs for Vaginal Fungal Infections Introduction
11.1.4 Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Bausch Health Companies Inc
11.2.1 Bausch Health Companies Inc Company Details
11.2.2 Bausch Health Companies Inc Business Overview
11.2.3 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Introduction
11.2.4 Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.2.5 Bausch Health Companies Inc Recent Development
11.3 ANl Pharmaceuticals, Inc
11.3.1 ANl Pharmaceuticals, Inc Company Details
11.3.2 ANl Pharmaceuticals, Inc Business Overview
11.3.3 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Introduction
11.3.4 ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.3.5 ANl Pharmaceuticals, Inc Recent Development
11.4 Hikma Pharmaceuticals Plc
11.4.1 Hikma Pharmaceuticals Plc Company Details
11.4.2 Hikma Pharmaceuticals Plc Business Overview
11.4.3 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Introduction
11.4.4 Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.4.5 Hikma Pharmaceuticals Plc Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Drugs for Vaginal Fungal Infections Introduction
11.5.4 Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.5.5 Lupin Limited Recent Development
11.6 Mycovia Pharmaceuticals, Inc.
11.6.1 Mycovia Pharmaceuticals, Inc. Company Details
11.6.2 Mycovia Pharmaceuticals, Inc. Business Overview
11.6.3 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Introduction
11.6.4 Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.6.5 Mycovia Pharmaceuticals, Inc. Recent Development
11.7 Glenmark Pharmaceuticals Limited
11.7.1 Glenmark Pharmaceuticals Limited Company Details
11.7.2 Glenmark Pharmaceuticals Limited Business Overview
11.7.3 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Introduction
11.7.4 Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.7.5 Glenmark Pharmaceuticals Limited Recent Development
11.8 Unique Pharmaceuticals
11.8.1 Unique Pharmaceuticals Company Details
11.8.2 Unique Pharmaceuticals Business Overview
11.8.3 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Introduction
11.8.4 Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.8.5 Unique Pharmaceuticals Recent Development
11.9 PEPTONIC Medical AB
11.9.1 PEPTONIC Medical AB Company Details
11.9.2 PEPTONIC Medical AB Business Overview
11.9.3 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Introduction
11.9.4 PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.9.5 PEPTONIC Medical AB Recent Development
11.10 Aurobindo Pharma Limited
11.10.1 Aurobindo Pharma Limited Company Details
11.10.2 Aurobindo Pharma Limited Business Overview
11.10.3 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Introduction
11.10.4 Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.10.5 Aurobindo Pharma Limited Recent Development
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Details
11.11.2 Dr. Reddy's Laboratories Business Overview
11.11.3 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Introduction
11.11.4 Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.11.5 Dr. Reddy's Laboratories Recent Development
11.12 SCYNEXIS,Inc.
11.12.1 SCYNEXIS,Inc. Company Details
11.12.2 SCYNEXIS,Inc. Business Overview
11.12.3 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Introduction
11.12.4 SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.12.5 SCYNEXIS,Inc. Recent Development
11.13 Basilea Pharmaceutica Ltd.
11.13.1 Basilea Pharmaceutica Ltd. Company Details
11.13.2 Basilea Pharmaceutica Ltd. Business Overview
11.13.3 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Introduction
11.13.4 Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.13.5 Basilea Pharmaceutica Ltd. Recent Development
11.14 Astellas Pharma lnc.
11.14.1 Astellas Pharma lnc. Company Details
11.14.2 Astellas Pharma lnc. Business Overview
11.14.3 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Introduction
11.14.4 Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.14.5 Astellas Pharma lnc. Recent Development
11.15 Grupo Ferrer Internacional,S.A.
11.15.1 Grupo Ferrer Internacional,S.A. Company Details
11.15.2 Grupo Ferrer Internacional,S.A. Business Overview
11.15.3 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Introduction
11.15.4 Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.15.5 Grupo Ferrer Internacional,S.A. Recent Development
11.16 Pacgen Life Science Corporation
11.16.1 Pacgen Life Science Corporation Company Details
11.16.2 Pacgen Life Science Corporation Business Overview
11.16.3 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Introduction
11.16.4 Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.16.5 Pacgen Life Science Corporation Recent Development
11.17 NovaDigm Therapeutics, Inc.
11.17.1 NovaDigm Therapeutics, Inc. Company Details
11.17.2 NovaDigm Therapeutics, Inc. Business Overview
11.17.3 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.17.4 NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.17.5 NovaDigm Therapeutics, Inc. Recent Development
11.18 Cidara Therapeutics, Inc.
11.18.1 Cidara Therapeutics, Inc. Company Details
11.18.2 Cidara Therapeutics, Inc. Business Overview
11.18.3 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Introduction
11.18.4 Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.18.5 Cidara Therapeutics, Inc. Recent Development
11.19 Amplyx Pharmaceuticals Inc.
11.19.1 Amplyx Pharmaceuticals Inc. Company Details
11.19.2 Amplyx Pharmaceuticals Inc. Business Overview
11.19.3 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Introduction
11.19.4 Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025)
11.19.5 Amplyx Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Bausch Health Companies Inc.
Hikma Pharmaceuticals PLC
Lupin Ltd
Mycovia Pharmaceuticals, Inc
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy’s Laboratories
Scynexis Inc
Basilea Pharmaceutica Ltd
Grupo Ferrer Internacional, S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc
Cidara Therapeutics, Inc
Amplyx Pharmaceuticals Inc
ANl Pharmaceuticals, Inc
Astellas Pharma lnc.
List of Tables
 Table 1. Global Drugs for Vaginal Fungal Infections Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Fluconazole
 Table 3. Key Players of Nystatin
 Table 4. Key Players of Flucytosine
 Table 5. Key Players of Clotrimazole
 Table 6. Key Players of Others
 Table 7. Global Drugs for Vaginal Fungal Infections Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Drugs for Vaginal Fungal Infections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Drugs for Vaginal Fungal Infections Market Share by Region (2020-2025)
 Table 11. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Drugs for Vaginal Fungal Infections Market Share by Region (2026-2031)
 Table 13. Drugs for Vaginal Fungal Infections Market Trends
 Table 14. Drugs for Vaginal Fungal Infections Market Drivers
 Table 15. Drugs for Vaginal Fungal Infections Market Challenges
 Table 16. Drugs for Vaginal Fungal Infections Market Restraints
 Table 17. Global Drugs for Vaginal Fungal Infections Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Drugs for Vaginal Fungal Infections Market Share by Players (2020-2025)
 Table 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
 Table 20. Ranking of Global Top Drugs for Vaginal Fungal Infections Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Drugs for Vaginal Fungal Infections Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Drugs for Vaginal Fungal Infections, Headquarters and Area Served
 Table 23. Global Key Players of Drugs for Vaginal Fungal Infections, Product and Application
 Table 24. Global Key Players of Drugs for Vaginal Fungal Infections, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Drugs for Vaginal Fungal Infections Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2020-2025)
 Table 28. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Type (2026-2031)
 Table 30. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2020-2025)
 Table 32. Global Drugs for Vaginal Fungal Infections Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Drugs for Vaginal Fungal Infections Revenue Market Share by Application (2026-2031)
 Table 34. North America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Pfizer Inc. Company Details
 Table 50. Pfizer Inc. Business Overview
 Table 51. Pfizer Inc. Drugs for Vaginal Fungal Infections Product
 Table 52. Pfizer Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 53. Pfizer Inc. Recent Development
 Table 54. Bausch Health Companies Inc Company Details
 Table 55. Bausch Health Companies Inc Business Overview
 Table 56. Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Product
 Table 57. Bausch Health Companies Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 58. Bausch Health Companies Inc Recent Development
 Table 59. ANl Pharmaceuticals, Inc Company Details
 Table 60. ANl Pharmaceuticals, Inc Business Overview
 Table 61. ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Product
 Table 62. ANl Pharmaceuticals, Inc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 63. ANl Pharmaceuticals, Inc Recent Development
 Table 64. Hikma Pharmaceuticals Plc Company Details
 Table 65. Hikma Pharmaceuticals Plc Business Overview
 Table 66. Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Product
 Table 67. Hikma Pharmaceuticals Plc Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 68. Hikma Pharmaceuticals Plc Recent Development
 Table 69. Lupin Limited Company Details
 Table 70. Lupin Limited Business Overview
 Table 71. Lupin Limited Drugs for Vaginal Fungal Infections Product
 Table 72. Lupin Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 73. Lupin Limited Recent Development
 Table 74. Mycovia Pharmaceuticals, Inc. Company Details
 Table 75. Mycovia Pharmaceuticals, Inc. Business Overview
 Table 76. Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Product
 Table 77. Mycovia Pharmaceuticals, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 78. Mycovia Pharmaceuticals, Inc. Recent Development
 Table 79. Glenmark Pharmaceuticals Limited Company Details
 Table 80. Glenmark Pharmaceuticals Limited Business Overview
 Table 81. Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Product
 Table 82. Glenmark Pharmaceuticals Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 83. Glenmark Pharmaceuticals Limited Recent Development
 Table 84. Unique Pharmaceuticals Company Details
 Table 85. Unique Pharmaceuticals Business Overview
 Table 86. Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Product
 Table 87. Unique Pharmaceuticals Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 88. Unique Pharmaceuticals Recent Development
 Table 89. PEPTONIC Medical AB Company Details
 Table 90. PEPTONIC Medical AB Business Overview
 Table 91. PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Product
 Table 92. PEPTONIC Medical AB Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 93. PEPTONIC Medical AB Recent Development
 Table 94. Aurobindo Pharma Limited Company Details
 Table 95. Aurobindo Pharma Limited Business Overview
 Table 96. Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Product
 Table 97. Aurobindo Pharma Limited Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 98. Aurobindo Pharma Limited Recent Development
 Table 99. Dr. Reddy's Laboratories Company Details
 Table 100. Dr. Reddy's Laboratories Business Overview
 Table 101. Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Product
 Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 103. Dr. Reddy's Laboratories Recent Development
 Table 104. SCYNEXIS,Inc. Company Details
 Table 105. SCYNEXIS,Inc. Business Overview
 Table 106. SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Product
 Table 107. SCYNEXIS,Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 108. SCYNEXIS,Inc. Recent Development
 Table 109. Basilea Pharmaceutica Ltd. Company Details
 Table 110. Basilea Pharmaceutica Ltd. Business Overview
 Table 111. Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Product
 Table 112. Basilea Pharmaceutica Ltd. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 113. Basilea Pharmaceutica Ltd. Recent Development
 Table 114. Astellas Pharma lnc. Company Details
 Table 115. Astellas Pharma lnc. Business Overview
 Table 116. Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Product
 Table 117. Astellas Pharma lnc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 118. Astellas Pharma lnc. Recent Development
 Table 119. Grupo Ferrer Internacional,S.A. Company Details
 Table 120. Grupo Ferrer Internacional,S.A. Business Overview
 Table 121. Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Product
 Table 122. Grupo Ferrer Internacional,S.A. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 123. Grupo Ferrer Internacional,S.A. Recent Development
 Table 124. Pacgen Life Science Corporation Company Details
 Table 125. Pacgen Life Science Corporation Business Overview
 Table 126. Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Product
 Table 127. Pacgen Life Science Corporation Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 128. Pacgen Life Science Corporation Recent Development
 Table 129. NovaDigm Therapeutics, Inc. Company Details
 Table 130. NovaDigm Therapeutics, Inc. Business Overview
 Table 131. NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
 Table 132. NovaDigm Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 133. NovaDigm Therapeutics, Inc. Recent Development
 Table 134. Cidara Therapeutics, Inc. Company Details
 Table 135. Cidara Therapeutics, Inc. Business Overview
 Table 136. Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Product
 Table 137. Cidara Therapeutics, Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 138. Cidara Therapeutics, Inc. Recent Development
 Table 139. Amplyx Pharmaceuticals Inc. Company Details
 Table 140. Amplyx Pharmaceuticals Inc. Business Overview
 Table 141. Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Product
 Table 142. Amplyx Pharmaceuticals Inc. Revenue in Drugs for Vaginal Fungal Infections Business (2020-2025) & (US$ Million)
 Table 143. Amplyx Pharmaceuticals Inc. Recent Development
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Drugs for Vaginal Fungal Infections Picture
 Figure 2. Global Drugs for Vaginal Fungal Infections Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drugs for Vaginal Fungal Infections Market Share by Type: 2024 VS 2031
 Figure 4. Fluconazole Features
 Figure 5. Nystatin Features
 Figure 6. Flucytosine Features
 Figure 7. Clotrimazole Features
 Figure 8. Others Features
 Figure 9. Global Drugs for Vaginal Fungal Infections Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drugs for Vaginal Fungal Infections Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Others Case Studies
 Figure 14. Drugs for Vaginal Fungal Infections Report Years Considered
 Figure 15. Global Drugs for Vaginal Fungal Infections Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Drugs for Vaginal Fungal Infections Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Drugs for Vaginal Fungal Infections Market Share by Region: 2024 VS 2031
 Figure 18. Global Drugs for Vaginal Fungal Infections Market Share by Players in 2024
 Figure 19. Global Top Drugs for Vaginal Fungal Infections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Vaginal Fungal Infections as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Drugs for Vaginal Fungal Infections Revenue in 2024
 Figure 21. North America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
 Figure 23. United States Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
 Figure 27. Germany Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Drugs for Vaginal Fungal Infections Market Share by Region (2020-2031)
 Figure 35. China Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
 Figure 43. Mexico Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Drugs for Vaginal Fungal Infections Market Share by Country (2020-2031)
 Figure 47. Turkey Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Drugs for Vaginal Fungal Infections Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Pfizer Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 51. Bausch Health Companies Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 52. ANl Pharmaceuticals, Inc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 53. Hikma Pharmaceuticals Plc Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 54. Lupin Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 55. Mycovia Pharmaceuticals, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 56. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 57. Unique Pharmaceuticals Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 58. PEPTONIC Medical AB Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 59. Aurobindo Pharma Limited Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 61. SCYNEXIS,Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 62. Basilea Pharmaceutica Ltd. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 63. Astellas Pharma lnc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 64. Grupo Ferrer Internacional,S.A. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 65. Pacgen Life Science Corporation Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 66. NovaDigm Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 67. Cidara Therapeutics, Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 68. Amplyx Pharmaceuticals Inc. Revenue Growth Rate in Drugs for Vaginal Fungal Infections Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Vaginal Antifungal Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diagnosing Fungal Infections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaginitis Therapeutics Market Insights Forecast to 2030
Invasive Fungal Infection Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaginal and Vulval Inflammatory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Candidiasis Therapeutics Market Research Report 2024
Global Topical Antifungals Market Research Report 2024
Fungal Nail Infections Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Antifungal Agents Market Insights Forecast to 2030
Systemic Aspergillosis and Systemic Candidiasis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antifungal Drugs Market Insights Forecast to 2030
White Fungus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti invasive Fungal Infection IFI Drug Market Research Report 2024
Global Oral Antifungals Market Insights Forecast to 2030
Global Aspergillosis Drugs Market Research Report 2024
Global Oral Antifungal Medication Market Insights Forecast to 2030
Global Medicinal Fungi Market Research Report 2024
Pharmaceutical Grade Voriconazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cryptococcosis Therapeutics Market Research Report 2024
Vaginal Fungi Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions